Active	Status	Sponsor type	Region	Phase	Filter
5 Active 4 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kaplan, David
SACRED, NCT03654053: Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis	Active, not recruiting	3	142	US	Placebo Oral Tablet, Placebo, Simvastatin 40mg, Simvastatin	VA Office of Research and Development	Cirrhosis	12/25	12/25
TAQE, NCT05842174: Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma	Not yet recruiting	1/2	93	US	Hydroxychloroquine, Lipiodol, Placebo	VA Office of Research and Development	Hepatocellular Carcinoma	08/27	08/28
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk	Recruiting	N/A	2500	US	Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test	Exact Sciences Corporation	Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer	01/25	04/26
PREMIUM, NCT05486572: Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI	Recruiting	N/A	4700	US	Abbreviated Magnetic Resonance Imaging with serum AFP, Abdominal Ultrasound Screening with serum AFP	VA Office of Research and Development	Carcinoma, Hepatocellular, Cirrhosis	09/30	09/31
Carothers, Brandy
NCT05336175: Biomarker Study: Heart Failure Patients at Risk	Not yet recruiting	1/2	40	US	Angiotensin 1-7, Saline solution	University of Arizona	Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV	12/23	12/23
Schlaifer, Amy
No trials found